{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:36:35Z","timestamp":1773416195235,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T00:00:00Z","timestamp":1437868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0852-5","type":"journal-article","created":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T05:07:47Z","timestamp":1437800867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Melinda","family":"Zeron Mullins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konia M.","family":"Trouton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,26]]},"reference":[{"issue":"4","key":"852_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.olq.0000235152.98601.d7","volume":"34","author":"P Nyirjesy","year":"2007","unstructured":"Nyirjesy P, McIntosh MJ, Steinmetz JI, Schumacher RJ, Joffrion JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal Mobiluncus morphotypes in patients with bacterial vaginosis. Sex Transm Dis. 2007;34(4):197\u2013202.","journal-title":"Sex Transm Dis"},{"key":"852_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1086\/375819","volume":"37","author":"TL Cherpes","year":"2003","unstructured":"Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37:319\u201325.","journal-title":"Clin Infect Dis"},{"key":"852_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1086\/367658","volume":"36","author":"HC Wiesenfeld","year":"2003","unstructured":"Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36:663\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"852_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1701-2163(16)32919-X","volume":"30","author":"MH Yudin","year":"2008","unstructured":"Yudin MH, Money DM, Infectious Diseases Committee. Screening and management of bacterial vaginosis in pregnancy. J Obstet Gynaecol Can. 2008;30(8):702\u201316.","journal-title":"J Obstet Gynaecol Can"},{"key":"852_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001251","volume":"9","author":"CR Cohen","year":"2012","unstructured":"Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012;9, e1001251.","journal-title":"PLoS Med"},{"key":"852_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/OLQ.0000000000000075","volume":"41","author":"JE Balkus","year":"2014","unstructured":"Balkus JE, Richardson BA, Rabe LK, Taha TE, Mgodi N, Kasaro MP, et al. Bacterial vaginosis and the risk of Trichomonas vaginalis acquisition among HIV-1-negative women. Sex Transm Dis. 2014;41:123\u20138.","journal-title":"Sex Transm Dis"},{"key":"852_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ajog.2007.04.001","volume":"196","author":"RS Gibbs","year":"2007","unstructured":"Gibbs RS. Asymptomatic bacterial vaginosis: is it time to treat? Am J Obs Gyne. 2007;196:495\u20136.","journal-title":"Am J Obs Gyne"},{"key":"852_CR8","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jama.291.11.1368","volume":"291","author":"MR Anderson","year":"2004","unstructured":"Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368\u201379.","journal-title":"JAMA"},{"key":"852_CR9","unstructured":"Canadian STI Guidelines: Section 4. Management and treatment of specific syndromes: vaginal discharge (bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis) 2013. http:\/\/www.phac-aspc.gc.ca\/std-mts\/sti-its\/cgsti-ldcits\/section-4-8-eng.php . Accessed 20 May 2015."},{"key":"852_CR10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol. 1991;29:297\u2013301.","journal-title":"J Clin Microbiol"},{"key":"852_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/S1064744998000027","volume":"6","author":"AM Wain","year":"1998","unstructured":"Wain AM. Metronidazole vaginal cream 0.75% (MetroGel-Vaginal): a brief review. Inf Dis Obs Gyne. 1998;6:3\u20137.","journal-title":"Inf Dis Obs Gyne"},{"key":"852_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2125.2005.02550.x","volume":"61","author":"JA Simoes","year":"2006","unstructured":"Simoes JA, Bahamondes LG, Camargo RP, Alves VM, Zaneveld LJ, Waller DP, et al. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharm. 2006;61:211\u20137.","journal-title":"Br J Clin Pharm"},{"issue":"5","key":"852_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1517\/14656566.2014.881800","volume":"15","author":"GG Donders","year":"2014","unstructured":"Donders GG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin Pharmacother. 2014;15(5):645\u201357.","journal-title":"Expert Opin Pharmacother"},{"key":"852_CR14","first-page":"443","volume":"41","author":"DG Ferris","year":"1995","unstructured":"Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract. 1995;41:443\u20139.","journal-title":"J Fam Pract"},{"key":"852_CR15","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1086\/514725","volume":"28","author":"MR Joesoef","year":"1999","unstructured":"Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Inf Dis. 1999;28:S57\u201365.","journal-title":"Clin Inf Dis"},{"key":"852_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1383\/medc.2005.33.10.58","volume":"33","author":"P Hay","year":"2005","unstructured":"Hay P. Bacterial vaginosis. Medicine. 2005;33:58\u201361.","journal-title":"Medicine"},{"key":"852_CR17","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S0020-7292(99)00133-2","volume":"67","author":"GP Schmid","year":"1999","unstructured":"Schmid GP. The epidemiology of bacterial vaginosis. Int J Gyne Obs. 1999;67:S17\u201320.","journal-title":"Int J Gyne Obs"},{"key":"852_CR18","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. JID. 2006;193:1478\u201387.","journal-title":"JID"},{"key":"852_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.ajog.2005.11.041","volume":"194","author":"JD Sobel","year":"2006","unstructured":"Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0.75\u00a0% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obs Gyne. 2006;194:1283\u20139.","journal-title":"Am J Obs Gyne"},{"key":"852_CR20","first-page":"889","volume":"45","author":"JM Hanson","year":"2000","unstructured":"Hanson JM, McGregor JA, Hillier SL, Eschenbach DA, Kreutner AK, Galask RP, et al. Metronidazole for bacterial vaginosis: a comparison of vaginal gel vs. oral therapy. J Reprod Med. 2000;45:889\u201396.","journal-title":"J Reprod Med"},{"key":"852_CR21","volume-title":"UpToDate\u00ae","author":"JD Sobel","year":"2015","unstructured":"Sobel JD. Bacterial vaginosis. In: Post TW, editor. UpToDate\u00ae. Waltham, MA: Wolters Kluwer; 2015."},{"key":"852_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9378(16)32581-9","volume":"141","author":"K Keller Van Slyke","year":"1981","unstructured":"Keller Van Slyke K, Michel VP, Rein MF. Treatment of vulvovaginal candidiasis with boric acid powder. Am J Obs Gyne. 1981;141:145\u20138.","journal-title":"Am J Obs Gyne"},{"key":"852_CR23","first-page":"893","volume":"43","author":"TE Swate","year":"1974","unstructured":"Swate TE, Weed JC. Boric acid treatment of vulvovaginal candidiasis. Obs Gyne. 1974;43:893\u20135.","journal-title":"Obs Gyne"},{"key":"852_CR24","first-page":"593","volume":"36","author":"R Jovanovic","year":"1991","unstructured":"Jovanovic R, Congema E, Nguyen HT. Antifungal agents vs boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med. 1991;36:593\u20137.","journal-title":"J Reprod Med"},{"key":"852_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/clind\/24.4.649","volume":"24","author":"JD Sobel","year":"1997","unstructured":"Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Inf Dis. 1997;24:649\u201352.","journal-title":"Clin Inf Dis"},{"key":"852_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1067\/mob.2001.111938","volume":"184","author":"S Guaschino","year":"2001","unstructured":"Guaschino S, De Seta F, Sartore A, Ricci G, De Santo D, Piccoli M, et al. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Am J Obs Gyne. 2001;184:598\u2013602.","journal-title":"Am J Obs Gyne"},{"key":"852_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1067\/S0002-9378(03)00726-9","volume":"189","author":"JD Sobel","year":"2003","unstructured":"Sobel JD, Chaim W, Nagappan V, Leaman D. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obs Gyne. 2003;189:1297\u2013300.","journal-title":"Am J Obs Gyne"},{"issue":"2","key":"852_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2337\/dc06-1469","volume":"30","author":"D Ray","year":"2007","unstructured":"Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, et al. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care. 2007;30(2):312\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"852_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jinf.2007.06.008","volume":"55","author":"D Ray","year":"2007","unstructured":"Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N. Prolonged (3 month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis. J Infect. 2007;55(4):374\u20137.","journal-title":"J Infect"},{"key":"852_CR30","first-page":"0815","volume":"2010","author":"D Spence","year":"2010","unstructured":"Spence D. Candidiasis (vulvovaginal). BMJ Clin Evid. 2010;2010:0815.","journal-title":"BMJ Clin Evid"},{"issue":"4","key":"852_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000314022","volume":"70","author":"GG Donders","year":"2010","unstructured":"Donders GG, Bellen G, Mendling W. Management of recurrent vulvo-vaginal candidosis as a chronic illness. Gyne Obs Invest. 2010;70(4):306\u201321.","journal-title":"Gyne Obs Invest"},{"issue":"11","key":"852_CR32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/OLQ.0b013e3181b08456","volume":"36","author":"O Reichman","year":"2009","unstructured":"Reichman O, Akins R, Sobel JD. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis. 2009;36(11):732\u20134.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"852_CR33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1128\/JCM.27.6.1266-1271.1989","volume":"27","author":"MA Krohn","year":"1989","unstructured":"Krohn MA, Hillier SL, Eschenbach DA. Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol. 1989;27(6):1266\u201371.","journal-title":"J Clin Microbiol"},{"key":"852_CR34","unstructured":"sealed envelope\u2122. Power (sample size) calculators. https:\/\/www.sealedenvelope.com\/power\/binary-noninferior\/ . Accessed 3 June 2015."},{"issue":"4","key":"852_CR35","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1080\/10543406.2013.789893","volume":"23","author":"E Hida","year":"2013","unstructured":"Hida E, Tango T. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints. J Biopharm Stat. 2013;23(4):774\u201389.","journal-title":"J Biopharm Stat"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0852-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0852-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0852-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T05:07:44Z","timestamp":1599368864000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0852-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,26]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0852-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,26]]},"assertion":[{"value":"21 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"315"}}